[ET Net News Agency, 24 July 2019] Evergrande Health Industry Group Limited (00708)
said a wholly-owned subsidiary of the company has entered into an agreement with hofer
Aktiengesellschaft (hofer AG).
Pursuant to the agreement, the parties agreed to establish a joint venture in Germany,
in which the group holds 67% interest whilst hofer AG holds 33% interest, with Mr Johann
HOFER serving as the chairman of the German Joint Venture.
The German Joint Venture, with hofer AG's cutting-edge technology and outstanding
research, development and manufacturing team in the powertrain field, will devote to
developing world-leading integrated powertrain core technology, and establishing an
advanced research and development production base in China. (RC)